分类： ACN Newswire

香港, 2026年5月13日 - (亚太商讯 via SeaPRwire.com) - 中国抗体制药有限公司（"中国抗体"或"公司"，连同旗下附属公司统称"集团"，股份代号：03681.HK）欣然宣布，公司执行董事、主席兼首席执行官梁瑞安博士作为特邀嘉宾，出席了近日在英国伦敦举办的2026 LifeArc转化科学峰会（LifeArc Translational Science Summit）。作为转化医学领域具有全球影响力的盛会之一，本届峰会汇聚了来自世界各地的顶尖科学家、临床医师、行业领袖、政策制定者及投资机构。梁瑞安博士在峰会中发表了主旨报告，系统分享了中国抗体在自身免疫疾病领域的研发策略与核心管线的最新临床进展，并与国际同行展开深入交流。本届峰会由英国知名医学研究慈善机构LifeArc主办。LifeArc长期致力于推动早期科学研究向临床应用的转化，尤其在罕见病及未满足医疗需求领域具有深远影响力。峰会聚焦转化研究如何通过推进新型治疗手段、重塑临床实践、影响卫生政策及驱动商业创新，加速从实验室发现到惠及患者的全过程。与会嘉宾围绕抗体药物、基因治疗、细胞治疗等前沿领域展开跨学科对话，探讨如何破解转化医学中的关键瓶颈，促进产学研医协同发展。梁瑞安博士的受邀，标志着中国抗体在创新免疫治疗领域的探索已获得国际权威机构的高度关注。在峰会主题报告中，梁瑞安博士深入剖析了全球自身免疫疾病药物研发的格局与挑战，并重点阐述了中国抗体以"全球首创（First-in-Class）与同类最优（Best-in-Class）"为核心的差异化创新策略。他详细介绍了公司核心产品SM17——一款靶向白细胞介素25（IL-25）受体的人源化单克隆抗体。SM17通过精准作用于II型免疫反应上游的关键"警戒素"分子IL-25受体，从源头抑制炎症级联反应，具有治疗特应性皮炎（AD）、炎症性肠病（IBD）、哮喘、慢性鼻窦炎伴鼻息肉及特发性肺纤维化等多种炎症免疫性疾病的广阔潜力。梁博士分享了SM17在近期取得的一系列实质性进展：在AD领域，SM17的1b期临床研究显示出卓越的疗效，高剂量组91.7%的患者实现瘙痒缓解（NRS-4），75%达到皮损恢复（EASI 75），41.7%达到完全或近乎完全清除AD症状（IGA 0/1），疗效数据显著优于现有IL-4/IL-13类单抗，且安全性优于JAK抑制剂；基于此，SM17治疗中重度AD的II期临床试验已于2026年3月31日在中国完成首例患者给药，计划入组约210名患者，预计2026年下半年完成全部入组，2027年上半年获得顶线数据。在给药便利性方面，SM17皮下制剂的I期桥接研究于2026年3月25日取得积极顶线结果，30名健康受试者的数据显示皮下注射具有良好的安全性和药代动力学特征，仅有一例1级注射部位皮疹并自行消退，绝对生物利用度稳健，为后续开发更便捷的皮下给药方案奠定了基础。此外，SM17的适应症已成功拓展至IBD，其新药临床试验申请（IND）于2026年2月24日获中国国家药监局正式批准，涵盖克罗恩病及溃疡性结肠炎，相关桥接研究已于2026年2月完成，将直接推进至II期临床开发。梁博士还介绍了公司早期管线的创新布局：抗CGC抗体（全球首创人源化抗γc抗体）在治疗斑秃、白癜风等自身免疫性疾病中展现出潜力，计划于2026年第四季度提交IND申请；靶向RANKL及骨硬化蛋白的双特异性抗体在骨相关适应症的临床前研究中显示出优于现有上市药物的疗效，计划于2027年上半年提交IND申请。梁博士强调，中国抗体通过深耕创新靶点，逐步构建起具有协同效应的产品矩阵，旨在为全球患者提供更安全、更有效、更便捷的突破性治疗方案。此次受邀出席LifeArc转化科学峰会，不仅体现了国际权威机构对中国抗体创新研发实力与前沿探索的高度认可，也为公司深化全球合作提供了重要平台。通过与全球顶尖科学家、临床研究者及跨国药企高管的深入交流，中国抗体进一步拓展了国际学术网络与潜在合作渠道，为未来技术引进、联合研发、对外授权及商业化落地奠定了坚实基础。梁瑞安博士表示，公司将继续聚焦自身免疫性疾病领域未满足的临床需求，加速推进SM17等核心管线的全球多中心临床开发，同时积极探索运用人工智能等新技术赋能新靶点发现，并依托与中山大学香港高等研究院等机构的战略合作，强化从实验室到临床的转化能力。展望未来，中国抗体将把握中国生物医药对外授权高速增长的历史机遇，坚持差异化的全球创新路径，积极寻求与全球伙伴的多元化合作模式，推动创新成果更快惠及全球患者，为股东创造长期价值。关于中国抗体制药有限公司中国抗体制药有限公司（股份代号：03681.HK）是首创新药及潜在同类最佳抗体药物研发领域的开拓者，专注于自身免疫性疾病、以及由此导致的神经系统疾病及其他难治的耗损性疾病，致力于解决未被满足的医疗需求。中国抗体始终致力于开发针对全新靶点及通过创新机制的治疗性抗体，旨在现有疗法效果不佳的领域实现差异化临床成果。其丰富的研发管线包括：SM17在AD治疗中展现出卓越的止痒效果、皮肤清除率及安全性，同时在哮喘和特发性肺纤维化（IPF）领域具有应用潜力；其旗舰抗CD22舒西利单抗，除了临床验证对类风湿关节炎（RA）具有临床疗效外，目前正针对系统性红斑狼疮（SLE）和阿尔茨海默病开展临床评估；另一款抗CGC（共同γ链）创新单抗，正准备进入治疗斑秃和白癜风的临床研究；中国抗体亦研发了一款能同时刺激骨骼生长及抑制骨骼流失、治疗骨质疏松症的双特异性抗体。中国抗体以突破性疗效为核心追求，不断重新定义患者护理标准，稳居突破性疗法领域的领军地位。此新闻稿由真灼财经代中国抗体制药有限公司发布投资者及媒体查询联络人：Bunny LeeNomia ZhouQiuyan Deng电话：（852）5316 9995电邮：ir_sinomab@zhenzhuoglobal.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 13, 2026 - (ACN Newswire via SeaPRwire.com) - SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”; stock code: 03681.HK) is pleased to announce that Dr. Shui On Leung, Executive Director, Chairman and Chief Executive Officer of the Company, was invited as a special guest to present at the 2026 LifeArc Translational Science Summit in London,UK. As one of the most influential global events in translational medicine, the summit brought together top scientists, practicing clinicians, industry leaders, policymakers and institutional investors from across the globe. During the event, Dr. Shui On Leung delivered a keynote speech, systematically outlining SinoMab’s R&D strategies for autoimmune diseases and the latest clinical progress of its core pipeline, while engaging in in-depth dialogues with international peers.Hosted by LifeArc, a prestigious UK medical research charity, the annual summit is committed to bridging early-stage scientific research and real-world clinical application, with profound expertise and influence in addressing rare diseases and wide-ranging unmet medical needs. This year’s summit centered on how translational research can accelerate the entire journey from laboratory discoveries to patient access, by advancing novel treatment modalities, transforming clinical practice, shaping health policies and driving commercial innovation. Attendees held interdisciplinary discussions on cutting-edge areas including antibody drugs, gene therapy and cell therapy, exploring solutions to break through core bottlenecks in translational medicine and boost integrated development across industry, academia, research and clinical sectors. Dr. Shui On Leung’s invitation to this high-profile event marks high recognition from leading international authorities of SinoMab’s innovative efforts in immunotherapy.In his keynote address, Dr. Shui On Leung analyzed the current landscape and prevailing challenges in global R&D for autoimmune disease therapeutics, and elaborated on SinoMab’s differentiated innovation framework anchored in “First-in-Class” and “Best-in-Class” drug development. He gave a detailed introduction to SM17, the Company’s flagship humanized monoclonal antibody targeting the interleukin-25 (IL-25) receptor. By precisely binding to IL-25 receptor, a key upstream alarmin molecule regulating type 2 immune responses, SM17 blocks inflammatory cascade reactions at the source. It holds broad therapeutic potential for a spectrum of inflammatory and immune-mediated disorders, including atopic dermatitis (AD), inflammatory bowel disease (IBD), asthma, chronic rhinosinusitis with nasal polyps, and idiopathic pulmonary fibrosis. Dr. Leung shared a series of landmark milestones achieved by SM17 recently. In the AD treatment landscape, Phase 1b clinical data demonstrated outstanding therapeutic efficacy. In the high-dose cohort, 91.7% of patients reported significant itch relief measured by the NRS-4 scale, 75% achieved EASI 75 skin lesion improvement, and 41.7% attained complete or near-complete clearance of AD symptoms (IGA 0/1). Such clinical outcomes outperform existing IL-4/IL-13 targeted monoclonal antibodies, while the product also boasts a more favorable safety profile compared with JAK inhibitors. Building on these promising results, the Phase II clinical trial of SM17 for moderate-to-severe AD completed first patient dosing in mainland China on 31 March 2026. The trial plans to enroll approximately 210 participants, with full enrollment expected in the second half of 2026 and topline clinical data slated for release in the first half of 2027. In terms of administration convenience, the Phase I bridging study of SM17 subcutaneous formulation released positive topline results on 25 March 2026. Data from 30 healthy volunteers confirmed the subcutaneous injection route with satisfactory safety and stable pharmacokinetic performance. Only one mild Grade 1 injection site rash was reported, which resolved spontaneously without intervention, and robust absolute bioavailability was validated, laying a solid foundation for the development of more user-friendly subcutaneous dosing regimens. Furthermore, SM17 has successfully expanded its therapeutic indications to IBD. Its Investigational New Drug (IND) application for Crohn’s disease and ulcerative colitis was officially approved by China’s National Medical Products Administration (NMPA) on 24 February 2026. Relevant bridging studies were finalized in the same month, paving the way for direct progression to Phase II clinical development. Dr. Leung also highlighted the Company’s innovative early-stage pipeline, including the anti-CGC antibody (a first-in-class humanized anti-γc antibody), which has demonstrated potential in the treatment of autoimmune diseases such as alopecia areata and vitiligo, with an IND submission planned for the fourth quarter of 2026. A novel bispecific antibody targeting RANKL and sclerostin has demonstrated superior efficacy over marketed therapies in preclinical studies for bone-related disorders, and its IND filing is targeted for the first half of 2027. Dr. Leung emphasized that by focusing on innovative and untapped drug targets, SinoMab has built a synergistic product portfolio, striving to deliver safer, more effective and more accessible breakthrough therapies for patients worldwide.Being invited to this LifeArc Translational Science Summit is not only a strong recognition from a respected international institution of SinoMab’s innovative edge and exploratory work in antibody R&D, but also a key opportunity to deepen our global partnerships. Through in-depth exchanges with leading scientists, clinical researchers and senior executives of multinational pharmaceutical companies, SinoMab has further expanded its international academic network and potential partnership channels, laying a solid foundation for future technology in-licensing, co-development, out-licensing and commercialization. Dr. Shui On Leung stated that the Company will remains focused on addressing unmet clinical needs in autoimmune diseases. It will accelerate global multi-center clinical development of core pipeline assets such as SM17, while actively exploring how AI and other new technologies can boost novel target discovery. In addition, drawing on strategic collaborations with institutions like the Sun Yat-sen University Institute of Advanced Studies Hong Kong, SinoMab aims to strengthen its translational capabilities from bench to bedside. Looking ahead, SinoMab will seize the rapid growth opportunities in China’s biotech out-licensing market, stay true to a differentiated global innovation path, and actively pursue diversified collaboration models with global partners, and accelerate the delivery of innovative therapies to patients worldwide, while creating long-term value for shareholders.About SinoMab BioScience LimitedSinoMab BioScience Limited (Stock Code: 03681.HK) is a pioneer in the research and development of first-in-class and potential best-in-class therapeutic antibody drugs, focusing on autoimmune diseases, neurodegenerative disorders, and other debilitating diseases, committed to addressing unmet medical needs. SinoMab has consistently focused on developing therapeutic antibodies targeting novel targets and employing innovative mechanisms, aiming to achieve differentiated clinical outcomes in areas where existing therapies have shown limited efficacy. Its rich R&D pipeline includes: SM17, which has demonstrated exceptional anti-pruritic effects, skin clearance rates, and safety profiles in the treatment of AD, with potential applications in asthma and idiopathic pulmonary fibrosis (IPF); its flagship anti-CD22 antibody, Suciraslimab , which has been clinically validated for efficacy in rheumatoid arthritis (RA) and is currently undergoing clinical evaluation for systemic lupus erythematosus (SLE) and Alzheimer's disease; another innovative anti-CGC (common gamma chain) monoclonal antibody, which is preparing to enter clinical studies for the treatment of alopecia areata and vitiligo; and a bispecific monoclonal antibody developed by SinoMab that simultaneously stimulates bone growth and inhibits bone loss for the treatment of osteoporosis. With breakthrough efficacy as its core pursuit, SinoMab continuously redefines patient care standards and maintains a leading position in the field of breakthrough therapies.  This press release is issued by Zhenzhuo Group on behalf of SinoMab BioScience Limited.Investor and Media InquiriesContact Person: Bunny LeeNomia ZhouQiuyan DengPhone: (852) 5316 9995Email: ir_sinomab@zhenzhuoglobal.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Anson Resources and POSCO Holdings have received board approval for a binding agreement to develop POSCO's Direct Lithium Extraction ("DLE") Demonstration Plant at the Green River Lithium Project in Utah.POSCO to lead the project at its own expense including the design, construction and operation of its proprietary Direct Lithium Extraction ("DLE") Demonstration PlantPOSCO to pay ~AUD $7.2 million (USD $5.2 million) non-dilutive facilitation fee to Anson.The collaboration positions Green River as a potential cornerstone asset in the emerging U.S. critical minerals and battery supply chain.During operation of the demonstration plant, the parties will evaluate broader commercial opportunities, including potential future joint investment and strategic cooperation.NEWPORT BEACH, CA, May 13, 2026 - (ACN Newswire via SeaPRwire.com) - Anson Resources Limited (ASX:ASN) ("Anson" or the "Company") is pleased to announce that both POSCO Holdings Inc. ("POSCO")'s board and the Company's board have approved the terms for a definitive Demonstration Plant Agreement ("Agreement") relating to the construction and operation of a Direct Lithium Extraction ("DLE") demonstration facility at the Green River Lithium Project in the Paradox Basin, Utah, USA.The board approvals mark a significant progression from the previously announced Memorandum of Understanding (see ASX Announcement 30 June 2025), establishing a framework under which POSCO will operate its own non-commercial DLE demonstration plant designed to validate lithium extraction at continuous industrial scale.Under the agreement POSCO committed to setting up its DLE demo-plant to extract lithium from brines produced from the Bosydaba #1 well owned by Anson at the Green River Lithium Project. POSCO will be responsible for engineering, construction, operation and maintenance of the facility, while Anson will provide access to property, infrastructure and brine supply. POSCO will pay Anson a non-dilutive facilitation fee of AUD ~$7.2 million (USD $5.2 million).The definitive agreement is expected to be signed before the end of Q2 2026. POSCO is expected to commence operation of the demonstration plant in 2027 and complete the work in 2028.The two companies will continue to explore potential business cooperation opportunities, including joint investment in the Project, during the operation of the demonstration plant, as outlined in the MoU Agreement, see ASX Announcement 30 June 2025.Strategic ImportanceDemonstrates strong industry validation of Green River's low-cost lithium potential.Accelerates technical de-risking through continuous demonstration-scale testing.Positions Green River as a key participant in the emerging U.S. domestic battery materials supply chain.Executive CommentaryExecutive Chairman & CEO, Mr. Bruce Richardson commented:"Securing a definitive agreement with POSCO represents a transformational step forward for the Green River Lithium Project.Moving from a non-binding MoU to a fully executed agreement underscores the strong technical confidence POSCO has in our asset and highlights the increasing strategic importance of domestic U.S. lithium supply."POSCO Holdings commented:"With the approval of the terms for a binding agreement, POSCO Holdings will advance validation of DLE technology in the United States and evaluate commercialisation pathways for future lithium production.We believe collaboration with Anson Resources at Green River will contribute to strengthening the North American lithium supply chain."Key Elements of the Definitive AgreementItemKey TermsProjectNon-commercial DLE Demonstration Plant - Green River Lithium ProjectResponsibilityPOSCO to bear cost for the design, construction, operations and maintenance for Demonstration PlantFacilitation FeeUSD $5.2MTermTo December 2028Brine SupplyProvided from Bosydaba #1 well with defined performance targetsAbout POSCO HoldingsPOSCO Holdings Inc. is a leading South Korean industrial group with strategic investments across steel, energy, and battery materials. POSCO Group is developing a global supply chain to support the transition EV and has invested in a total of 93,000 tonnes of lithium production annually in Argentina and South Korea. The company has made significant investments in both brine and hard-rock lithium resources across South America and Australia and is advancing proprietary Direct Lithium Extraction (DLE) technologies to accelerate low-carbon lithium production.This announcement has been authorized for release by the Executive Chairman and POSCO Holdings.For further information please contact:Bruce Richardson Will MazeExecutive Chairman and CEO Head of Investor RelationsE: info@Ansonresources.com E: investors@Ansonresources.comPh: +61 7 3132 7990 Ph: +61 7 3132 7990www.Ansonresources.com Follow us on Twitter @Anson_irSOURCE: Anson Resources Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - Anytime Fitness (the “Company”), a globally renowned 24-hour fitness chain, has seen strong growth across the Asia-Pacific region in recent years. Benefiting from a significant rise in public health awareness in the post-pandemic era, it has continued to accelerate its market expansion. In particular, Hong Kong, as a strategic growth market for the Company, is expected to reach the milestone of 50 clubs by the end of the year. A further 25 clubs have already secured funding, with potential to open an additional 30 to 40 clubs over the next few years. Meanwhile, the Company projects that its total number of clubs across the Asia-Pacific region will reach 2,500 to 3,000 over the next two to three years, underscoring its long-term commitment to and confidence in the regional market.A Truly Global Brand, Powered by Regional ExpertiseAnytime Fitness operates as a truly global brand, with a presence across 42 countries and territories on all seven continents, offering members seamless access to clubs worldwide. Unlike competitors that are merely international, Anytime Fitness delivers a globally connected fitness ecosystem, combining scale, consistency, and member-centric innovation.In Asia-Pacific, growth is led by Inspire Brands Asia (“IBA”), the master franchisee for Anytime Fitness across key markets including Hong Kong, Singapore, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, and Malaysia. This structure enables strong regional execution while maintaining global brand standards.Community-Based Approach: Replicating Singapore’s Success in Hong KongThe core philosophy of Anytime Fitness is to bring fitness services into the community and provide a convenient, stress-free workout experience — a model that has proven successful worldwide. Ryan Cheal, Group Chief Operating Officer of IBA, said: “As a highly mature market in the region, we’ve sold around 200 franchises and operate more than 160 clubs in Singapore. Its market penetration and consumer patterns have provided a clear blueprint for our expansion in Hong Kong. With a similar market profile but a larger population base, Hong Kong offers substantial potential for community-based development. We are confident that we can replicate the success achieved in Singapore, and expect that once Hong Kong surpasses the critical milestone of 50 clubs, network effects will drive even faster growth.”Franchising Drives Scalable Expansion with End-to-End Support for PartnersIn terms of its operating model, Anytime Fitness operates a hybrid model of corporate-owned and franchised clubs. Currently, around 50% of clubs in Hong Kong are corporate-owned, enabling the brand to gain deep insights into the local market and provide more effective support to franchise partners. In contrast, the proportion of corporate-owned clubs in Singapore stands at around 20%. This structure ensures that the Company can maintain high service standards and brand consistency while expanding rapidly.The Company’s franchise ecosystem offers end-to-end support, including:- Site selection and club development; - Equipment and operational setup; - Marketing and member acquisition; - Training and business coaching for franchise partners. This integrated approach ensures consistency in member experience while enabling rapid and sustainable expansion. At present, around 80% of new clubs are opened by existing franchisees. Investors from sectors such as retail and F&B are also increasingly shifting their investments towards the health industry, demonstrating the model’s strong appeal and the market’s recognition of its growth potential.Tech-Powered Member Experience: Building a Comprehensive Health EcosystemIn response to the trend of intelligent transformation, Anytime Fitness is actively leveraging technology to enhance service value. To enhance member experience, Anytime Fitness continues to invest in technology and personalised wellness solutions. Its next-generation member app integrates:- Personalised training plans; - Class and trainer bookings;- Recovery guidance and nutrition support.The ecosystem is further supported by tools such as Evolt, a body composition analysis system capable of measuring over 40 biometric indicators, giving members deeper insight into their health and fitness progress. Currently, the app’s average daily member usage rate is around 30% to 35%, effectively strengthening user engagement and retention.Understanding the Hong Kong Member: Strength, Wellness, and LifestyleRecent member insights highlight evolving fitness priorities in Hong Kong:- 57% of members (3 in 5) prioritise strength training; - 16% (1 in 6) are driven by broader wellness goals, including mental health and overall lifestyle improvement. These trends reflect a structural shift in consumer behaviour, where fitness is no longer discretionary, but an essential part of modern living.Focusing on “Essential Health Needs” and “Human-Centered Connection”, with a Stable and Positive Industry OutlookDespite the complex macroeconomic environment, the Company remains optimistic about the outlook for the industry. Ryan noted that the fitness population is continuing to grow, with participation among seniors steadily increasing and health awareness rising. Consumer spending priorities are also undergoing a structural shift, with health and fitness having evolved from “discretionary spending” to “essential lifestyle”. Notably, younger demographics have shown a particularly strong willingness to invest in health, wellness, and longevity, providing the industry with resilience that transcends economic cycles.Looking ahead, Anytime Fitness will continue to innovate its products and services. It launched a new club design last month, enhancing the strength training and exercise recovery areas, and plans to further improve its nutrition guidance services next year. Ryan concluded, “In this technology-driven era, the Company will continue to uphold the core value of ‘human-centered connection’, using convenient, friendly, and professional services to help more people establish consistent exercise habits and embrace a healthier lifestyle. We are confident in the Asia-Pacific and Hong Kong markets and believe that future growth will be even faster and more innovative.”About Anytime FitnessAnytime Fitness is the largest and fastest-growing global fitness brands in the world, averaging 300 new clubs per year while serving over 5 million members at nearly 6,000 clubs in 42 countries and territories on all seven continents. Open 24-hours a day, 365 days a year, Anytime Fitness delivers personalized and affordable health and wellness training, coaching, nutrition, and recovery guidance for our members—in the club, in their homes, in their pockets, wherever they are and anytime they need it. All franchised clubs are individually owned and operated, and members have access to any Anytime Fitness club worldwide.For more information, please visit：https://www.anytimefitness.com/.Media Inquiries:Inspire Brand AsiaJerry Chow Email: Jerry.chow@inspirebrandsasia.com  Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TAMPA, FLA., May 12, 2026 - (ACN Newswire via SeaPRwire.com) - The Global Technology Distribution Council (GTDC), the world's largest consortium of technology distributors, named V.S. Hariharan, Managing Director and Group CEO of Redington Limited, to its Executive Committee. The committee provides operational oversight and helps guide GTDC's long-term strategy, advancing the organization's mission to strengthen distribution's role in the global technology marketplace."Hari is a respected global IT leader and a strong advocate for distribution," said Frank Vitagliano, CEO of GTDC. "He brings valuable insight to our leadership team and will help shape our long-term strategy and initiatives that highlight the expanding role of distributors in today's technology ecosystem."GTDC's executive leadership group oversees the organization's vision, develops and updates its strategic plans and advocates for its members' common interests. Comprised of senior executives from member distributors, the EC carries out the non-profit association's mission to educate, advocate and influence the tech community on the evolving role of IT distributors. Council leaders also sponsor and oversee GTDC research, the association's three regional executive level events and other member driven initiatives. Hariharan will support these efforts, strengthening partnerships between distributors and vendors and reinforcing distribution's value across the global technology marketplace."Delivering innovative solutions that meet the evolving needs of the technology community has been my core focus at Redington, and I look forward to working with other distribution leaders to serve GTDC in a similar capacity," said Hariharan. "As a Technology Orchestrator, we are focused on connecting partners, platforms and possibilities to unlock next opportunities across markets. I see this role as a natural extension of that commitment, and look forward to strengthening collaboration, sharpening our view of global industry trends, and helping the ecosystem navigate the opportunities and challenges ahead."Hariharan is the Managing Director and Group CEO of Redington, an $11.8 billion distribution and supply chain solutions provider, where he leads operations across 40 markets. A seasoned industry leader, he brings over 35 years of experience across sales, marketing, and general management, including senior leadership roles at Hewlett Packard and Wipro Infotech, along with entrepreneurial experience in scaling solar solutions for off grid markets.Under his leadership, Redington is accelerating its role as a Technology Orchestrator, bringing together OEMs and partnersQ to drive innovation, agility, and growth across emerging markets.About the GTDCThe Global Technology Distribution Council is the industry consortium representing the world's leading technology distributors. GTDC members drive an estimated $180 billion in annual worldwide sales of products, services and solutions through diverse business channels. GTDC conferences foster strategic supply-chain partnerships that address the fast-changing needs of vendors, end customers and distributors. Members include AB S.A, Arrow Electronics, CMS Distribution, Computer Gross Italia S.p.A., D&H Distributing, ELKO Group, Esprinet S.p.A., Exclusive Networks, Exertis, Infinigate, Ingram Micro, Intcomex, Logicom Public Limited, Mindware, Nexora, Redington Limited, SiS Technologies, Tarsus Distribution, TD SYNNEX, TIM AG and Westcon-Comstor.Brian ShermanCommCentric Solutions (on behalf of GTDC)814-882-4432bsherman@commcentric.comSOURCE: Global Technology Distribution Council Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - May 12, 2026) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that the Company has signed a 3 year lease, with options for term extension, to support production expansion and to provide additional office space for staff. The site is within the Richlands suburb of Brisbane, nearby to the existing headquarters of the Company. The site has over 2,100 square metres of covered space — including offices, meeting rooms and a high ceiling warehouse.Craig Nicol, CEO & Managing Director of the Company, commented "This is the first site for expansion for our company — for both staff and production assets. We will look to expand our production assets here after the Gen 2 Project is completed — which is expected at the end of June 2026."Jack Perkowski, Non-Executive Chairman and Director of the Company, commented: "As we look to expand our production plants around the world — this is the first significant step in our global growth plan."Operations UpdateGMG is focused on delivering its Gen 2.0 Graphene Production Project (the "Gen 2.0 Project") by end of June 2026 — which is expected to produce at least 10 tonnes per annum of graphene at its headquarters in Richlands, Queensland, Australia.Once the Gen 2.0 Project is commissioned and operating, GMG plans to replicate and establish other production plants around the world to enable scaled production for potential sales, diversify and lower production risks, and reduce operating costs by locating the plant in countries with lower operating costs, including low cost natural gas — one of GMG's key production input costs.Currently, GMG is planning three potential expansion projects — two in North America (potentially one in US and one in Canada) in addition to an expansion production project in Australia (located on the expansion lease outlined in this release). GMG proposes to mature these projects and expand production in line with sales for all of its products.The expansion program for GMG includes the following 5 production plants:Graphene Production (from natural gas)Coating Blend Plant (for the graphene coating THERMAL-XR®)Lubricant Blend Plant (for the graphene lubricant additive G® LUBRICANT)Graphene Slurry Plant (for the SUPA G Lithium-Ion Battery Additive)Battery Assembly Plant (for the Graphene Aluminium Ion Battery)Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/297118_53e7bb85547cbaac_001full.jpgAbout GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed at improving the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "believes" "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements as to GMG's focus on, and the timing and production expectations of, the Gen 2 Project, intentions regarding the number, purpose and location of expansion projects, intentions to de-risk, reduce operating costs and develop commercial scale-up capabilities, GMG's focus in the energy savings segment, GMG's intentions for the use of graphene lubricant additive on saving liquid fuels, expectations for R&D and commercialization of G+AI Batteries, GMG's ability to improve the performance of lithium-ion batteries and GMG's critical business objectives.Such forward-looking statements are based on a number of assumptions of management, including the patent and potential market size of G® LUBRICANT. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation that GMG does not receive or receive on a timely basis the fully signed consent notice from the and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297118 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

CALGARY, AB AND VANCOUVER, BC / ACN Newswire via SeaPRwire.com / May 12, 2026 / CANEX Metals Inc. ("CANEX") (TSXV:CANX) and Gold Basin Resources Corporation ("Gold Basin") (TSXV:GXX) are pleased to announce that they have entered into a definitive agreement (the "Arrangement Agreement") to combine their respective businesses by way of a plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement"). The combined company will be managed by the CANEX executive team.Under the terms of the Arrangement, shareholders of Gold Basin ("Gold Basin Shareholders") will receive 0.592 shares of CANEX ("CANEX Shares") per share of Gold Basin ("Shares") held, the same consideration received by Gold Basin Shareholders who tendered to the CANEX offer to acquire Shares which expired on February 10, 2026. This represents a premium of 242.0% to the last trading price of the Shares prior to the Cease Trade Order, based on the closing price of the CANEX Shares as of May 8, 2026.Dr. Shane Ebert, President and CEO of CANEX stated: "Today's announcement of an agreement to combine the two companies will allow us to consolidate and advance a promising gold district in Arizona. CANEX will be pleased to welcome Gold Basin Shareholders as new shareholders of CANEX."Jordan Ross, independent director and Chair of the Gold Basin Special Committee, commented: "The Arrangement Agreement represents a strategic milestone for our shareholders. By partnering with CANEX, we are unlocking the full potential of our Arizona project while providing a stable, clear-cut path forward that resolves previous liquidity and regulatory challenges. Following a rigorous review with our professional advisors, we are confident this agreement offers the most robust and value-driven future for our investors."Benefits to Gold Basin ShareholdersSignificant Upfront Premium to Shareholders. The consideration offered under the Arrangement represents a 242.0% premium to the last trading price of the Shares prior to the Cease Trade Order, based on the closing price of the CANEX Shares as of May 8, 2026.Consolidation of Gold Districts and Near-Term Exploration and Expansion. The Arrangement will consolidate an advanced oxide gold exploration camp in Mohave County, Arizona hosting multiple zones of gold mineralization with strong drill results across an eight kilometre by eight kilometre area, opening up potential near-term exploration on favourable targets.Diversification. Completing the Arrangement will provide Gold Basin Shareholders not only with exposure to a consolidated gold district in Mohave County, Arizona, but also to CANEX's Louise Project in British Columbia. On July 31, 2025, CANEX announced results from an induced polarization geophysical survey which identified a new and previously unknown chargeability target two kilometres west of the historic Louise deposit and a large steeply dipping zone of high chargeability below and to the north of the historic Louise deposit.Focused, Professional and Cost-Effective Management Team. The Arrangement places the consolidated district under CANEX's highly focused, professional and cost-effective management team, which will provide strong operational and governance oversight.Experienced Board of Directors. Following the Arrangement, the Resulting Issuer's board of directors will be led by experienced industry professionals, comprised of members of the current board of directors of CANEX.Liquidity. The Arrangement will provide Gold Basin Shareholders with a more liquid investment. On May 6, 2025, the British Columbia Securities Commission imposed a Cease Trade Order against the Gold Basin Shares. The next day, the Canadian Investment Regulatory Organization imposed a halt in trading of the Gold Basin Shares on the TSXV. There is no expectation that the Cease Trade Order will be rescinded if the Arrangement were not to proceed and Gold Basin were to continue with the status quo.Enhanced Financial Capacity. CANEX has demonstrated an ability to raise capital and has strong support from a number of high profile industry professionals. With an enhanced capital markets profile, the Resulting Issuer is expected have even better access to lower-cost capital and an increased capability to advance its exploration properties.Going Concern. In the absence of the Arrangement, there is considerable risk that Gold Basin will not have the ability to continue as a going concern and realize its assets and discharge its liabilities in the normal course of business. Currently, Gold Basin has asserted liabilities of over $2 million, no cash or marketable securities and no revenue. Gold Basin's ability to raise equity financing is restricted by the Cease Trade Order.Details of the ArrangementCANEX and Gold Basin entered into a definitive Arrangement Agreement on May 11, 2026, pursuant to which CANEX will acquire all of the issued and outstanding common shares of Gold Basin ("Gold Basin Shares") by way of a statutory plan of arrangement under the Business Corporations Act (British Columbia).Holders of Gold Basin Shares ("Gold Basin Shareholders") will receive 0.592 common shares in the capital of CANEX (the "CANEX Shares", and such ratio being the "Exchange Ratio") in exchange for each Gold Basin Share held immediately prior to the effective time of the Arrangement. Upon completion of the Arrangement, existing holders of CANEX Shares and former Gold Basin Shareholders will own approximately 67.7% and 32.3% of the total issued and outstanding CANEX Shares, respectively, on a fully diluted basis.CANEX expects to issue an aggregate of approximately 38,505,033 CANEX Shares to Gold Basin Shareholders, based on the number of Gold Basin Shares outstanding as at the date of this announcement.The Arrangement is expected to close in June 2026, subject to the receipt of all required court, shareholder, regulatory, and stock exchange approvals. Following completion of the Arrangement, the CANEX Shares will remain listed on the TSXV and the Gold Basin Shares will be delisted from the TSXV.Term LoanConcurrently with the entering into of the Arrangement Agreement, CANEX and Gold Basin have agreed to enter into a senior secured term loan (the "Term Loan") as soon as practicable pursuant to which CANEX will lend up to $900,000 to Gold Basin at an interest rate per annum equal to the Royal Bank of Canada Prime Rate plus 5.0%. The maturity of the Term Loan shall be six months and the Term Loan shall be secured by a first ranking general security agreement over all of Gold Basin's present and after-acquired assets, a first ranking mortgage charge over Gold Basin's split mineral rights and first ranking security agreements encumbering all of Gold Basin's other mineral tenure. The proceeds from the Term Loan will be used by Gold Basin for aged payables, day to day working capital and general corporate expenditures, direct advances paid by CANEX to third party suppliers, service providers and creditors of Gold Basin, and expenses in connection with the Arrangement. The Term Loan is not contingent on the completion of the Arrangement.The Term Loan is subject to the approval of the TSXV. No fees are payable in connection with the Term Loan.Arrangement Conditions and TimingThe Arrangement will be effected by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia) and will require the approval of: (i) at least 66⅔% of votes cast by Gold Basin Shareholders, and (ii) a simple majority of the votes cast by disinterested Gold Basin Shareholders, excluding for this purpose the votes held by any person specified under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions. The Gold Basin Shares held by CANEX will not be excluded from either vote. CANEX currently holds 70,088,199 Gold Basin Shares, representing 51.86% of the issued and outstanding Gold Basin Shares.The Arrangement Agreement includes customary representations and warranties for a transaction of this nature as well as customary interim period covenants regarding the operation of CANEX's and Gold Basin's businesses. The Arrangement Agreement also includes customary deal protections in favour of each of CANEX and Gold Basin. With respect to CANEX, these protections include non-solicitation covenants, and a right to match any superior proposals. With respect to Gold Basin, these protections include a fiduciary-out provision. The Arrangement Agreement includes a termination fee of $211,777 payable by Gold Basin in the event the Arrangement Agreement is terminated in certain circumstances.In addition to securityholder and court approvals, the Arrangement is subject to applicable regulatory approvals, stock exchange approvals and the satisfaction of certain other closing conditions customary in transactions of this nature.None of the securities to be issued pursuant to the Arrangement have been or will be registered under the U.S. Securities Act, or any state securities laws, and any securities issuable in the Arrangement are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Section 3(a)(10) of the U.S. Securities Act and applicable exemptions under state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.Further details of the Arrangement will be included in a management information circular to be prepared by Gold Basin (the "Gold Basin Circular") that will be delivered to Gold Basin Shareholders in advance of a special meeting of Gold Basin Shareholders (the "Gold Basin Meeting") which is scheduled to be held on June 4, 2026. A copy of the Arrangement Agreement will be made available on CANEX's and Gold Basin's respective SEDAR+ profiles at www.sedarplus.com. The Gold Basin Circular will also be made available on Gold Basin's SEDAR+ profile in advance of the Gold Basin Meeting.Board of Directors' and Special Committee RecommendationBased on the recommendation of a special committee comprised of an independent director of Gold Basin (the "Special Committee") and after consultation with independent external financial and legal advisors, the board of directors of Gold Basin (the "Gold Basin Board") unanimously approved the Arrangement and has determined the Arrangement is in the best interests of Gold Basin, and that the consideration to be received by Gold Basin Shareholders is fair, from a financial point of view, to Gold Basin Shareholders (other than CANEX). The Gold Basin Board unanimously recommends that Gold Basin Shareholders vote in favour of the Arrangement at the Gold Basin Meeting.Stifel Nicolaus Canada Inc. has provided a fairness opinions to the Gold Basin Board and Special Committee in connection with the Arrangement.Voting Support AgreementsEach of Gold Basin's directors and officers support the Arrangement and all who own Shares have entered into customary voting support agreements agreeing to vote their Gold Basin Shares, respectively, in favor of the Arrangement. The voting support agreement may be terminated in certain circumstances, including, without limitation, upon termination of the Arrangement Agreement.About CANEX MetalsCANEX Metals (TSX.V:CANX) is a Canadian junior exploration company and the controlling shareholder of Gold Basin Resources, owning 51.86% of Gold Basin. CANEX is advancing its 100% owned Gold Range Project in Mohave County, Arizona. With several near surface bulk tonnage gold discoveries made to date across a 4 km gold mineralized trend, the Gold Range Project is a compelling early-stage opportunity for investors. Gold Basin Resources holds the adjacent Gold Basin Project which hosts large, mineralized trends containing near surface oxide gold mineralization and has seen over 800 historic and current drill holes into mineralized deposits up to 1.7 kilometres in length.CANEX is also advancing the Louise Copper-Gold Porphyry Project in British Columbia. Louise contains a large historic copper-gold resource that has seen very little deep or lateral exploration, offering investors copper and gold discovery potential. CANEX is led by an experienced management team which has made three notable porphyry and bulk tonnage discoveries in North America and is sponsored by Altius Minerals (TSX: ALS), a large shareholder of the Company.About Gold Basin Resources CorporationGold Basin Resources Corporation holds the Gold Basin Project in Mohave County Arizona. The project hosts large, mineralized trends containing near surface oxide gold mineralization and has seen over 800 historic and current drill holes into mineralized deposits up to 1.7 kilometres in length."Shane Ebert"Shane Ebert, President/Director of CANEX and Gold BasinFor Further Information Contact:Shane Ebert at 1.250.964.2699 orJean Pierre Jutras at 1.403.233.2636Web: http://www.canexmetals.caNeither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Although information provided by Gold Basin for inclusion in this news release is believed by CANEX to be reliable, CANEX has not independently verified such information and cannot provide any assurance of its accuracy, currency, reliability or completeness. Although information provided by CANEX for inclusion in this news release is believed by Gold Basin to be reliable, Gold Basin has not independently verified such information and cannot provide any assurance of its accuracy, currency, reliability or completeness.Forward-Looking StatementsThis news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", "potential", "risk", "anticipated", "future", or "opportunity" or variations of such words and phrases or stating that certain actions, events or results "may", "can", "shall" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.In this news release, forward-looking statements relate to, among other things, statements regarding: the proposed acquisition by CANEX of all of the Gold Basin Shares pursuant to the Arrangement and the terms thereof; the benefits of the Arrangement; the receipt of necessary shareholder, court and regulatory approvals for the Arrangement; the anticipated timeline for completing the Arrangement; the Gold Basin Meeting and mailing of the management information circular regarding the same; the Term Loan; the terms and conditions pursuant to which the Arrangement will be completed, if at all; the anticipated benefits of the Arrangement; the anticipated filing of materials on SEDAR+; and continuation of CANEX and delisting of Gold Basin. These forward-looking statements are not guarantees of future results and involve risks and uncertainties that may cause actual results to differ materially from the potential results discussed in the forward-looking statements.In respect of the forward-looking statements, CANEX and Gold Basin have relied on certain assumptions that they believe are reasonable at this time, including assumptions as to the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court, shareholder, stock exchange and other third party approvals and the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the Arrangement. This timeline may change for a number of reasons, including unforeseen delays in preparing meeting materials; inability to secure necessary regulatory, court, shareholder, stock exchange or other third-party approvals in the time assumed or the need for additional time to satisfy the other conditions to the completion of the Arrangement. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times.Risks and uncertainties that may cause such differences include but are not limited to: the risk that the Arrangement or the Term Loan may not be completed on a timely basis, if at all; the conditions to the consummation of the Arrangement or the Term Loan may not be satisfied; the risk that the Arrangement or the Term Loan may involve unexpected costs, liabilities or delays; the possibility that legal proceedings may be instituted against CANEX, Gold Basin, and/or others relating to the Arrangement or the Term Loan and the outcome of such proceedings; the possible occurrence of an event, change or other circumstance that could result in termination of the Arrangement Agreement; risks relating to the failure to obtain necessary regulatory, court, shareholder, and stock exchange approvals; other risks inherent in the mining industry. Failure to obtain the requisite approvals, or the failure of the parties to otherwise satisfy the conditions to or complete the Arrangement or Term Loan, may result in the Arrangement or Term Loan not being completed on the proposed terms, or at all. In addition, if the Arrangement or Term Loan are not completed, the announcement of the Arrangement and the Term Loan and the dedication of substantial resources of CANEX and Gold Basin to complete the Arrangement and the Term Loan could have a material adverse impact on each of CANEX's and Gold Basin's share price, its current business relationships and on the current and future operations, financial condition, and prospects of each of CANEX and Gold Basin. CANEX and Gold Basin disclaim any responsibility to update these forward-looking statements, except as required by applicable laws.SOURCE: Gold Basin Resources Corporation Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月12日 - (亚太商讯 via SeaPRwire.com) - 近日，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"，股份代号：1788.HK）作为独家全球协调人，圆满协助蒙古国家银行（State Bank of Mongolia）完成1亿美元Reg S债券增发。本次发行为蒙古国家银行2025年9月首次2亿美元3年期债券的增发，发行完成后，该期债券存续规模增至3亿美元。发行人获穆迪授予"B1"发行人评级，评级展望"稳定"，与蒙古主权评级一致。本次发行亦获得蒙古财政部及蒙古中央银行出具的正式支持函。本次增发定价收益率为8.5%，较原发行8.9%的水平显著优化，既体现蒙古国家银行稳健的财务基本面，也反映国际投资者对蒙古经济前景的信心持续提升。 本次债券增发顺利落地，是蒙古国家银行在国际资本市场的重要里程碑，亦是国泰君安国际继2025年9月助力其首次完成2亿美元3年期债券后，与该行的再度深度合作，彰显双方高度互信与长期默契。面对复杂多变的全球资本市场环境，国泰君安国际精准把握市场窗口、高效完成项目执行，既进一步巩固了公司服务非大中华区域发行人开展境外债券融资的业务布局，也充分展现了其在全球资本市场的专业定价、全球投资者资源整合及跨市场综合金融服务能力。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK），是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高质量、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的信息请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - Recently, Guotai Junan International Holdings Limited (“Guotai Junan International” or “GTJAI”, Stock Code: 1788.HK), a subsidiary of Guotai Haitong Group, successfully assisted the State Bank of Mongolia in completing a US$100 million Reg S bond tap issuance as the sole global coordinator. This issuance is a tap-on of the State Bank (Mongolia) initial US$ 200 million 3-year bond issued in September 2025. Upon completion of this tap issuance, the outstanding size of the bond has increased to US$300 million.The issuer has been assigned a “B1” issuer rating by Moody’s, with a “stable” outlook, aligned with Mongolia’s sovereign rating. This issuance also received formal support letters from the Ministry of Finance of Mongolia and the Central Bank of Mongolia. The tap offering was priced at a yield of 8.5%, representing a significant improvement from the original issuance's level of 8.9%. This not only reflects the solid financial fundamentals of the State Bank (Mongolia), but also signals continuously growing confidence among international investors in Mongolia’s economic prospects.The successful completion of this bond tap issuance marks a significant milestone for the State Bank (Mongolia) in the international capital markets. It also represents another in-depth collaboration between the bank and GTJAI, following the latter’s assistance in the bank’s initial US$200 million 3-year bond issuance in September 2025, demonstrating the high level of mutual trust and long-term rapport between the two parties. Amid a complex and volatile global capital market environment, GTJAI precisely seized the market window and efficiently executed the project. This not only further strengthens the Company’s business presence in facilitating offshore bond financing for issuers outside the Greater China region, but also fully showcases its capabilities in professional pricing, global investor resource integration, and cross-market comprehensive financial services in the global capital markets.About GTJAIGuotai Junan International (Stock Code: 1788.HK), a subsidiary of Guotai Haitong Group, is the market leader and first mover for internationalization of Chinese Securities Company as well as the first Chinese securities broker listed on the Main Board of The Hong Kong Stock Exchange through initial public offering. Based in Hong Kong with subsidiaries in Singapore, Vietnam and Macau, GTJAI’s business covers major markets around the world, offering high-quality and diversified comprehensive financial services for clients' overseas asset allocation. Core business includes wealth management, institutional investor services, corporate finance services, investment management and other business. GTJAI has been assigned “Baa2” and “BBB+” long term issuer rating from Moody and Standard & Poor respectively, as well as an MSCI ESG “AAA” rating, Wind ESG “A” rating and SynTao Green Finance “A” rating in ESG. Additionally, its S&P Global ESG score leads 81% of its global peers. The controlling shareholder, Guotai Haitong Securities (Stock Code: 601211.SH/ 2611.HK), is the comprehensive financial provider with a long-term, sustainable and overall leading position in the China’s capital markets. For more information about GTJAI, please visit https://www.gtjai.com. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - May 12, 2026) - Casa Minerals Inc. (TSXV: CASA) (OTCQB: CASXF) (FSE: 0CM) ("CASA" or the "Company") is pleased to report that it has received aggregate gross proceeds of $432,777.30 to date in 2026 through the exercise of 4,453,364 common share purchase warrants (the "Warrants").The Warrants were originally issued pursuant to the Company's private placements completed in April of 2025 and February of 2026. Each Warrant entitled the holder to acquire one common share of the Company upon exercise.Net proceeds will be deployed to advance Casa's 2026 exploration programs at the Congress Gold Mine in Arizona and the Arsenault Copper-Gold-Silver Project in British Columbia, and for general working capital purposes."The continued support from our warrant holders is greatly appreciated," said Farshad Shirvani, President and Chief Executive Officer. "This additional capital meaningfully strengthens our balance sheet as we mobilize for an aggressive 2026 drilling and exploration season across our core projects."​​About Casa Minerals Inc.Casa Minerals Inc. is a mineral exploration company focused on gold, copper, and strategic minerals exploration in North America. The Company holds a 90% interest in the historic Congress Gold Mine in Arizona and is advancing multiple projects in British Columbia, including the Arsenault copper-gold-silver project. Casa's experienced management team is committed to creating shareholder value through the discovery and development of economic mineral deposits. For more information, please visit: www.casaminerals.comON BEHALF OF THE BOARD OF DIRECTORSFarshad Shirvani, M.Sc. GeologyPresident, CEO and DirectorFor more information, please contact:Casa Minerals Inc.Farshad Shirvani, President & CEOPhone: (604) 678-9587Email: contact@casaminerals.comNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297081 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月12日 - (亚太商讯 via SeaPRwire.com) - 全球知名24小时连锁健身品牌Anytime Fitness（"公司"）近年于亚太区发展强劲，受惠于后疫情时代公众健康意识显著提升，市场拓展步伐持续加快。其中，香港作为策略性增长市场，预计年内场馆总数达50间之里程碑，另有逾25间已获资金支持，未来数年更有潜力增设30至40间场馆。同时，公司预测未来二至三年，亚太区场馆总数将达2,500至3,000间，展现其对区域市场的长期承诺与信心。真正全球品牌 区域专业赋能Anytime Fitness作为真正的全球品牌，业务覆盖7大洲共42个国家及地区，会员可于全球各场馆无缝畅行。不同于同业仅具国际化布局，Anytime Fitness构建了全球互联的健身生态体系，兼具规模优势、服务一致性，以及以会员为本的创新能力。于亚太区，Inspire Brands Asia（"IBA"）作为Anytime Fitness在香港、新加坡、泰国、菲律宾、印尼、越南、台湾及马来西亚等重点市场的总特许经营商，推动业务增长。此架构既有助于强化区域执行力，又能维持全球品牌标准的一致性。以社区为本 复制新加坡经验至香港Anytime Fitness的核心理念是将健身服务带入社区，并提供便捷、无压力的健身体验，此模式于全球验证成功。IBA集团首席营运总裁Ryan Cheal表示："新加坡作为区域内高度成熟的市场，已授出约200个特许经营权，营运场馆逾160间，其市场渗透率与消费模式为香港提供了清晰的发展蓝图。香港与新加坡市场高度相似，且人口基数更大，极具社区发展潜力。我们有信心复制新加坡的成功经验，预计香港于突破50间场馆之临界点后，网络效应将带动更快增长。"特许经营驱动规模扩张 全链支持合作伙伴营运模式方面，Anytime Fitness 采用特许经营与直营并行。目前香港约50%场馆为品牌直营，此举旨在深入理解本地市场，以更有效地支持特许经营合作伙伴。另外，新加坡市场的直营比例约20%，此结构确保公司于快速扩张的同时，能维持高品质的服务标准与品牌一致性。公司特许经营生态提供全链支持，包括：- 选址及场馆建设；- 设备配置及营运筹备；- 营销及会员招募；- 特许经营合作伙伴培训及业务指导。此整合模式既可确保会员体验的一致性，又能实现迅速且可持续的扩张。目前，公司约80%的新增场馆来自现有特许经营商，零售、餐饮等行业投资者亦呈转投健康产业之趋势，印证了该模式的强大吸引力与市场对其增长潜力的认可。科技赋能会员体验 构建全方位健康生态面对智慧化趋势，Anytime Fitness积极以科技提升服务价值。为提升会员体验，Anytime Fitness 持续投资于科技及个人化的健康方案，其新一代会员应用程式整合以下功能：- 个人化训练计划；- 课堂及教练预约；- 恢复指导及营养建议。此生态系统亦配备多种仪器，例如Evolt身体成分分析仪，可测量逾40项生物指标，令会员更深入掌握自身健康与健身进展。目前，应用程式日均会员使用率约30%至35%，有效巩固用户参与度与黏性。洞悉香港会员：力量训练、身心健康与生活方式最新会员洞察显示，香港会员的健身目标优先级正在转变：- 57%的会员（每五人中有三人）以力量训练为首要目标；- 16%的会员（每六人中有一人）则更注重整体健康，包括心理健康及整体生活方式的改善。上述趋势反映出消费者行为的结构性转变：健身不再只是可有可无的选择，而是现代生活不可或缺的一部分。聚焦"健康刚需"与"人性化连接" 行业前景稳健向好尽管宏观经济仍显复杂，公司对行业前景保持乐观。Ryan指出，当前健身人群持续扩大，长者参与健身人数逐步上升，健康意识亦不断提升；大众消费优先次序正经历结构性转变，健康与健身已由"可选消费"转变为"生活必需"。值得一提的是，年轻族群对健康、保健与长寿的投资意愿尤为显著，为行业带来穿越周期的韧性。展望未来，Anytime Fitness将持续进行产品与服务创新。公司已于上月推出全新场馆设计，强化力量训练与运动恢复区域，并计划于明年进一步优化营养指导服务。Ryan总结："科技时代，Anytime Fitness 将坚持‘人性化连接’的核心价值，以便利、友善、专业的服务，令更多人建立恒常运动习惯，开启健康生活。我们对亚太及香港市场充满信心，相信未来发展将更快速、更具创新性。"关于Anytime FitnessAnytime Fitness是全球规模最大、发展最快的健身品牌之一，每年新增场馆约300间，现已覆盖全球7大洲42个国家和地区的逾5,600间场馆，为逾500万会员提供服务。无论会员身处何方，该品牌都能全年365天、全天24小时开放，随时为会员于场馆、家中和移动设备上，提供他们所需的个性化、可负担的健康保健训练、指导、营养和恢复服务。所有特许经营的场馆均为独立所有及营运，会员可以进入全球任一Anytime Fitness场馆。如欲索取更多资料，请浏览以下网址：https://www.anytimefitness.com/。新闻垂询：Inspire Brand AsiaJerry Chow 电邮: Jerry.chow@inspirebrandsasia.com  Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

MUMBAI, INDIA, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - CleverTap, the all-in-one customer engagement platform, has won Silver at the Thailand MarTech Awards 2026 in the Impact MarTech category, in partnership with Rabbit Rewards, the loyalty and lifestyle platform for Bangkok’s BTS Skytrain and a widely used commuter ecosystem in Southeast Asia.The recognition highlights how CleverTap and Rabbit Rewards have transformed customer engagement by building a real-time, agentic engagement model powered by autonomous decisioning, designed to serve millions of commuters in a high-frequency environment.Rabbit Rewards operates at the intersection of daily commuting, payments, and lifestyle services, where user behavior shifts constantly based on routine, timing, and location. Traditional campaign-led approaches, built on static segmentation and fixed schedules, were unable to keep pace and often resulted in delayed or irrelevant engagement.To address this, Rabbit Rewards partnered with CleverTap to implement a real-time decisioning layer that continuously interprets live behavior and determines the next best action for each user.With CleverAI™, and its suite of tools — including IntelliNODE and Best Time Optimization among others — Rabbit Rewards deployed trigger-based, omnichannel journeys across push notifications, in-app messaging, email, and SMS. These journeys span onboarding, renewals, promotions, and re-engagement, and adapt continuously to commuter behavior.The shift to real-time, behavior-led engagement delivered clear, measurable outcomes:85% uplift in click-through rates (CTR)62.6% week-4 repeat transactions among engaged users, compared to 18.7% for non-engaged users2.4% of total transactions directly influenced by CleverTap-powered engagementBeyond these results, Rabbit Rewards significantly improved the quality of customer engagement. Communication became more timely, contextual, and aligned with commuter needs, strengthening trust and positioning the platform as a more intuitive, lifestyle-oriented companion for daily users.“Our vision has always been to make everyday commuting more seamless, rewarding, and relevant for our users. Through our partnership with CleverTap, we have successfully transitioned from traditional campaign execution to a real-time engagement model that understands and responds to commuter behavior in the moment.CleverAI™ has enabled us to deliver more personalized and timely experiences at scale, strengthening both customer engagement and long-term loyalty. This collaboration goes beyond technology — it is about ensuring Rabbit Rewards shows up for our members in ways that feel personal, timely, and genuinely useful throughout their daily journeys,” said Kamolwan Korphaisarn, Program Director, Rabbit Rewards“Enterprises today sit on a surplus of data, but turning those data points into timely, meaningful action remains a big challenge. With CleverAI™, we’re enabling brands to move beyond static campaigns to intelligent systems that continuously interpret behavior, determine the next best action, and deliver truly personalized experiences in real time. Our work with Rabbit Rewards shows how this approach drives stronger engagement while enabling seamless, context-aware customer journeys at the scale of the individual,” said Anand Jain, Co-founder and Chief Marketing Officer, CleverTap.About Rabbit RewardsRabbit Rewards is Thailand’s leading loyalty and lifestyle platform built around Bangkok’s BTS Skytrain ecosystem, one of Southeast Asia’s busiest urban transit networks serving millions of daily commuters.The platform connects commuting, payments, and everyday lifestyle experiences into a single ecosystem, enabling members to access rewards, offers, and partner benefits across Bangkok.As part of BTS Group Holdings, Rabbit Rewards serves a diverse member base ranging from daily riders and students to tourists and lifestyle-focused members, making it a deeply embedded companion in Bangkok’s urban lifestyle.Rabbit Rewards continues to evolve its customer engagement capabilities to deliver more contextual, real-time experiences that align with the rhythm of everyday commuting and lifestyle needs.For more information, visit rabbitrewards.co.thAbout CleverTapCleverTap is the world’s leading AI-first, all-in-one customer engagement and retention platform, helping brands turn data into lasting customer relationships. Powered by its proprietary CleverAI™: Decisioning Engine and Agentic AI-verse, CleverTap enables organizations to maximize customer lifetime value at scale. Its unified platform brings together AI-powered segmentation, personalization, experimentation, journey orchestration, and deep analytics—seamlessly integrated with 100+ leading martech solutions.Leading brands such as Burger King, Levi’s, IKEA, Decathlon, Domino’s, Jio, Carousell, AIA Thailand, Sasom, 12Go, and Ngern Tid Lor,  rely on CleverTap to drive measurable growth through meaningful customer engagement. With backing from global investors including Accel, Peak XV Partners, Tiger Global, CDPQ, and 360 One, CleverTap has presence across  US, Europe, the Middle East, Latin America, and Asia.For more information, visit clevertap.com or follow us on:LinkedIn: https://www.linkedin.com/company/clevertap/X: https://twitter.com/CleverTapFor more information:ADITYA SANYALDirector, Digital Marketing, CleverTap+91 9177110080aditya.sanyal@clevertap.comASHMIT CHAUDHARYAssociate Consultant, Archetype+91 8850752121ashmit.chaudhary@archetype.co Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - May 11, 2026, Gold Peak Technology Group Limited (SEHK: 40) completed a syndicated green and sustainability-linked loan facility (the “GSLL Facility”) of HK$675 million with 10 major banks. With Hang Seng Bank Limited as the mandated lead arranger and bookrunner, Shanghai Commercial Bank Limited is the mandated lead arranger and Malayan Banking Berhad the lead arranger. Other arrangers include Chang Hwa Commercial Bank, Ltd. Hong Kong Branch; Bank of Dongguan International Limited; China Zheshang Bank Co., Ltd. Hong Kong Branch; Taiwan Cooperative Bank, Ltd. Hong Kong Branch; Taiwan Shin Kong Commercial Bank Co., Ltd., Hong Kong Branch; First Commercial Bank, Ltd., Macau Branch; and Hua Nan Commercial Bank, Ltd., Offshore Banking Branch.Notwithstanding the challenging global environment, this HK$675 million GSLL Facility underscores strong confidence and backing from the banking sector in Gold Peak’s commitment to, and track record of, upholding and advancing Environmental, Social, and Governance (“ESG”) principles.Victor Lo, Chairman & Chief Executive of Gold Peak, said, “Gold Peak remains steadfast in its commitment to long-term sustainable development and has consistently demonstrated its ability to deliver in this area. The establishment of the GSLL Facility not only validates our strategic direction but also enables us to explore innovative financing options and adopt operational best practices that will drive sustainable business growth.”Dr Brian Li, Vice Chairman and Executive Vice President of Gold Peak, commented, “As a prominent player in the batteries, audio, and electronics industries, Gold Peak is committed to embedding sustainability into every aspect of its operations. We have made solid and measurable progress in advancing our sustainability strategy, reflecting our dedication to responsible corporate citizenship and long-term value creation.”“We champion the use of rechargeable batteries to reduce waste. Our GP Recyko rechargeable range has been met with strong market acceptance, and we are continuously improving our charging efficiency to enable full charging in just one hour, a boost to shifting the consumers’ habit from single-use batteries to rechargeables.”“We continued to reinforce our packaging sustainability efforts by replacing plastic packaging with paper-based alternatives for more than 1,000 GP-branded consumer battery products across Europe. As a result of this initiative, we achieved an annual reduction of 48 tons of plastic and 30 tons of material waste.”GP Energy Tech, the Group’s sustainable energy solutions business, reached a key milestone with the opening of our first Nickel Zinc (NiZn) manufacturing facility in Dongguan, China, in January 2026. This marks an important step toward positioning Gold Peak to develop next- generation NiZn battery solutions, engineered to enhance immediate power performance through high power density, improved recyclability, and non-flammable characteristics.The NiZn batteries are designed to provide reliable, sustainable power for Uninterruptible Power Supply (UPS) systems for data centers and other critical infrastructures. Through the GSLL Facility, the Group will receive funding to further advance the NiZn initiative — supporting progress toward a safer and more sustainable future.Gold Peak views sustainability as a crucial value driver for achieving profitable, long-term growth. In FY24/25, it achieved a 4% year on year reduction in Scope 1 and Scope 2 greenhouse gas emissions compared to FY23/24 baseline year. It remains committed to its interim and long-term reduction targets as follows:- a 20% reduction by 2030 compared to the FY23/24 baseline;- a 60% reduction by 2040; and- the achievement of net-zero operational emissions (i.e., 100% reduction) by 2050.Among many sustainability awards, six of the Group’s battery manufacturing facilities have achieved Zero Waste to Landfill Platinum and Gold validation from UL Solutions, demonstrating its commitment to diverting 95-100% of waste from landfills through effective waste reduction and diversion strategies. Additionally, GP Batteries and GP Energy Tech have gained EcoVadis Bronze medal during FY25/26. The Group is also continuously ramping up the solar panels in factories to realize its decarbonization goals.Regina Lee, Head of Commercial Banking at Hang Seng Bank Limited, said, “This syndicated facility reflects the market’s confidence in Gold Peak’s long-term strategy and sustainability efforts. Hang Seng Bank is honoured to act as sole mandated lead arranger and bookrunner for a green and sustainability-linked loan facility, delivering a structure that incentivises performance against clear sustainability targets and supporting the Group’s continued investment in rechargeable battery manufacturing. Building on our long-standing relationship with Gold Peak, we’ll continue to work closely with the Group to align financing with sustainability outcomes, creating long-term value for stakeholders and the wider community.”The 3-year GSLL Facility features a tiered incentive mechanism that rewards progress toward sustainability targets, with Gold Peak eligible for an interest rate reduction upon achievement. Gold Peak plans to deploy the proceeds to further strengthen its financial position, accelerate the expansion of its rechargeable battery and sustainable energy solutions businesses, support long-term investment in advanced manufacturing technologies, drive operational excellence, and deepen its commitment to green and sustainable business practices.(Center) Brian Li, Vice Chairman and Executive Vice President of Gold Peak, signed the GSLL Facility of HK$675 million with 10 major banks.(7th from the left) Victor Lo, Chairman and Chief Executive of Gold Peak, expressed gratitude to the banks for their continued and unwavering support of the GSLL Facility.Gold Peak Technology Group Limited Charlotte WongSenior Manager, Corporate Communications Tel: (852) 2485 5328Email: charlotte_wong@goldpeak.comAJA Capital LimitedAvy Yu / Janet LouieTel: (852) 9500 4443 / (852) 9155 5615Email:avy.yu@ajacapital.com.hk / janet.louie@ajacapital.com.hkAbout Gold PeakGold Peak Technology Group is a global battery and electronics company with an aspiration to become one of the leaders in providing energy and sound solutions that enlighten and empower lives, and with sustainability as a focus.The parent company, Gold Peak Technology Group Limited (SEHK: 40), was established in 1964 and has been listed on the Stock Exchange of Hong Kong since 1984. Gold Peak holds a majority stake at 86.18%* in the Singapore-listed GP Industries Limited as its major industrial investment vehicle and operates manufacturing, R&D, marketing and distribution operations in more than 10 countries around the world.Gold Peak Technology Group Limited not only develops its consumer batteries, electronics and audio products, but also puts great emphasis on R&D of new rechargeable battery and B2B battery technologies. The Group has built renowned brand names for its major product categories, including GP batteries, GP Recyko batteries, KEF premium audio products and Celestion professional speaker drivers.www.goldpeak.com(* shareholding % as at 11 May 2026) Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 11, 2026 - (ACN Newswire via SeaPRwire.com) - The fifth International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), opens today, featuring two flagship events. The sixth Asia Summit on Global Health (ASGH) is being held today and tomorrow (11 and 12 May) at the Hong Kong Convention and Exhibition Centre (HKCEC) under the theme “Fuelling Healthcare Breakthroughs”. The summit convenes over 90 influential international healthcare officials, research and medical experts, start-ups, investors, and business leaders from related industries to explore global healthcare trends, with a focus on frontier technologies, AI breakthroughs, pandemic preparedness, silver health, as well as innovation in Chinese medicine, in alignment with the National 15th Five-Year Plan. Another flagship event, the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair), also opens today (11 to 13 May) under the theme “Innovations Boosting Smart Health Experience”, featuring some 300 exhibitors from 10 countries and regions. The Fair spotlights MedTech, GeronTech and Preventive Healthcare, showcasing the latest medical innovations integrating artificial intelligence and robotics, fostering global exchange in healthcare innovation and reinforcing Hong Kong’s strengths as a research and commercial hub.Prof Frederick Ma, Chairman of the HKTDC, said in his welcome remarks: “There is nowhere better than Hong Kong, as a major international hub for financing and innovation, to explore areas of global collaboration in the health arena, and to showcase related business opportunities for investors and project owners. As a superconnector and super value-adder, Hong Kong has a long track record of helping companies and innovations break through. The theme we have adopted this year, ‘Fuelling Healthcare Breakthroughs’, highlights this vital role. The ASGH was created to nurture partnerships and knowledge exchange that can drive real change and create a better world. This year’s agenda also complements the healthcare priorities set out in China’s new 15th Five-Year Plan, supporting national development. Among the diverse topics at ASGH 2026 are sessions examining AI-enabled diagnosis and treatment, biomedical innovation, the growth of the silver health economy, traditional Chinese medicine and much more.”John Lee, Chief Executive of the HKSAR, said in his opening remarks: “Hong Kong, under the ‘one country, two systems’ principle, is investing in healthcare and, in doing so, investing in the future of our people and our economy. Our status as a leading hub for scientific innovation is unrivalled in Asia. And our strengths are magnified by our core position in the Guangdong-Hong Kong-Macao Greater Bay Area. That is the cluster city development integrating 11 dynamic cities in southern China. It boasts a collective economy that rivals that of the world's 10th-largest nation. In pursuit of medical innovation, Hong Kong complements the strategies set out in the National 15th Five-Year Plan. The Plan optimises an evaluation and approval mechanism for innovative drugs and supports their clinical application. The goal is to develop Hong Kong into a health and medical innovation hub. Central to this ambition is the rapid expansion of our clinical trial capabilities, the vital engine that drives biomedical R&D from the laboratory to the bedside.”Prof Zeng Yixin, Vice Minister of the National Health Commission of the People’s Republic of China, delivered special remarks: “Hong Kong has extensive experience in undergraduate medical education and post-graduate training, and enjoys a strong reputation in the Asia-Pacific region. Medical talent training system on the mainland is also undergoing deep reforms and striving to move towards high-quality development. Hong Kong has many experiences and practices that are worthy of in-depth exchange and reference, which will certainly promote mutual enhancement and progress.”Global leaders convene to explore collaboration opportunitiesThis morning’s Plenary Session I: Strengthening Pandemic Preparedness through Global Collaboration, featured keynote speech by Prof Lo Chung-mau, Secretary for Health of the HKSAR government, who said: “Hong Kong has long been recognised for the quality and efficiency of our healthcare system. We consistently rank at the top of global health indices, with a life expectancy that remains among the highest in the world, with women over 88 years and men about 83 years in 2024. Our public healthcare system serves as a robust safety net, ensuring universal health coverage for all at a very low cost. The National 15th Five-Year Plan calls for a health-first development strategy. Hong Kong is fully aligned and will continue to contribute to this national vision through our work in pandemic preparedness and medical innovation.”Prof Leo Poon, Daniel C K Yu Professor in Virology at the School of Public Health of the University of Hong Kong and Co-Director of the Hong Kong Jockey Club Global Health Institute, moderated the session. Distinguished speakers included Prof Ibrahim Abubakar, Vice-Provost (Health) and Professor of Infectious Disease Epidemiology at University College London; Feng Lan, Vice President, China Pharmaceutical Innovation and Research Development Association; Dr Leung Yiu-hong, Head of Emergency Response and Programme Management Branch, Department of Health of the HKSAR government; Dr Kumanan Rasanathan, Executive Director of the WHO Alliance for Health Policy and Systems Research; Prof Wang Yu, Chairman of the Chinese Foundation for Hepatitis Prevention and Control, also Former Director-General, Chinese Centre for Disease Control and Prevention; and Dr In-Kyu Yoon, Deputy Director General for Integrated Development and Pandemic Preparedness at the International Vaccine Institute. They discussed key strategies to strengthen the resilience of the global health system in response to future pandemics. Dr Kumanan Rasanathan said: “Public health agencies need to maintain scientific independence to synthesize, act upon, and provide advice based on the best available science. They also require operational flexibility because, during a pandemic or outbreak, it is not sufficient to rely solely on strategies used for previous outbreaks.”Plenary Session II: Fuelling Healthcare Breakthroughs was moderated by Victor Chu, Chairman and CEO of First Eastern Investment Group. Speakers included Clara Chan, CEO of Hong Kong Investment Corporation Limited; David Lau, Vice Chair of Investment Banking for Asia Pacific and Head of Healthcare Investment Banking for Asia Pacific at JP Morgan Securities; Dr Inna Menkova, Chief Executive Officer, Allogenica; Jonathan Symonds, Chairman of the Board of GSK; and Theresa Tse, Chairwoman of the Board, Sino Biopharmaceutical Limited; They examined investment trends and market transformation in biopharmaceuticals and explored how cross-sector collaboration can drive healthcare breakthroughs.One of the highlights this afternoon, the Dialogue with Global Pioneer in Health session, featured 2013 Nobel Prize laureate in Chemistry, Prof Michael Levitt, Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University. He shared insights into his research and the future of technology-driven healthcare innovation, exploring how biological intelligence is shaping the future of healthcare. He said: “One of the secrets of successful evolution is to be as diverse as possible. This diversity then leads to intelligence.”Thematic sessions spotlight cutting-edge healthcare innovation and AI applicationsAs the global healthcare industry accelerates towards technology-driven transformation and industrial upgrading, multiple thematic sessions at the summit focus on the application of innovative technologies across the sector. Topics include AI-enabled healthcare, medical robotics and devices, cell and gene therapies, biomedical, and the silver economy, showcasing the latest market trends and aligning with the National 15th Five-Year Plan to advance the development of a “Healthy China” and foster AI and healthcare innovation. The first day featured a dedicated session, The Next Frontier in China's Healthcare Industry, moderated by Nisa Leung, Managing Partner of Aulis Capital, with speakers including Mark Gavin Lotter, Founder and CEO of Nuance Pharma; Wu Hao, Executive Director and Co-President of Tigermed; and Seth Zhang, Founder and CEO of MediTrust Health. They discussed strategies to drive the development of the Chinese Mainland healthcare sector. Wu Hao said: “By giving China-led industry data and applications greater exposure and participation on the global stage, Chinese enterprises can take a seat at the table and become true leaders.”Several thematic sessions spotlight the large-scale application of AI in healthcare. These include this afternoon’s sessions: Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution, moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong, featured speakers including Prof Joshua Ho, Assistant Dean (Innovation and Technology Transfer) in the Li Ka Shing Faculty of Medicine at the University of Hong Kong; and Reshaping Tomorrow’s Healthcare: Advances in Medical Robotics and Devices, further explored the transformative role of AI in medical robotics and next-generation medical devices, showcasing cutting-edge innovations and breakthrough developments. Tomorrow afternoon’s session, Transforming Healthcare through Digital Health & AI Innovations, with speakers from Healthtech Finland, Heidi Health, Pfizer, The Hong Kong Polytechnic University and other leading organisations, will offer multi-dimensional insight into AI applications and breakthroughs in the healthcare field.A new session this year, CSO Insights: Catalysing Scientific Breakthroughs and Investments for Future Health, will bring together leading scientists from global pharmaceutical companies, including Dr Li Xiang, Senior Vice President, Co-President and Chief Scientific Officer of Innovative Medicines Division at Fosun Pharma, to discuss transforming research breakthroughs into real-world healthcare applications.Building on last year’s Silver Health Chapter, tomorrow will feature the session Unlocking Growth in Silver Health: From Precision Medicine to Smart Ageing Innovations. Speakers include Prof Christopher Chao, Vice President (Research and Innovation) of the Hong Kong Polytechnic University; Prof Brian Kennedy, Director of the Centre for Healthy Longevity at the National University Health System, Singapore; and Zhang Junjie, Vice President of Ant Group and President of Healthcare Business Group. They will share insights into ageing-related disease prevention and solutions.Other sessions also cover a wide range of cutting-edge topics, including Driving Chinese Medicine Development Through Standardisation and Innovation, and IP Financing and Trading for Pharmaceutical and Health Technology. These thematic sessions examine the latest developments and trends in the healthcare industry from multiple perspectives, promoting exchanges among scientific research, market applications and industry policy. During the session From Detection to Cure: Accelerating Innovations for Rare Diseases, Prof Liang Zicai, Founder and Chairman of Suzhou Ribo Life Science, will explore how innovative diagnostics and treatments are bringing new hope to patients. Another session, Charting the Future: A New Era in Gene and Cell Therapies, brought together Dr Li Xiang, Founder and CEO of XellSmart, and Dr Zhu Tian, Co-founder and CEO of GenEditBio, who shared the latest advancements in stem cell biology and genome editing platforms with other guests.    A global platform for healthcare resource matching, empowering pharmaceutical and healthcare companies to expand their businessIn addition to symposium sessions, some 180 healthtech companies from 12 countries and regions are showcasing innovative projects and solutions at the ASGH Business Hub and InnoHealth Showcase. At the same time, Project Pitching provides start-ups with opportunities to connect with investors, while the ASGH Deal-making facilitate one-on-one meetings to match global capital with healthcare projects. Participants can also access professional advice at the “GoGlobal Connect” and Business of Healthcare Advisory Zone, enabling companies to develop more targeted strategies for business expansion.Medical Fair showcases diverse AI-driven health solutions, with smart ageing products surge twofoldThe 17th Hong Kong International Medical and Healthcare Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, opened alongside ASGH. With the theme Innovations Boosting Smart Health Experience, the Fair brings together some 300 exhibitors from 10 countries and regions, including Hong Kong, the Chinese Mainland, Taiwan, Korea, as well as new participants from Macao, Australia, Canada, New Zealand, Vietnam and the United States, highlighting Hong Kong’s strengths as an international medical innovation hub.The Fair focuses on three key areas: MedTech, GeronTech and Preventive Healthcare, presenting a comprehensive showcase of the latest medical and healthcare equipment, products and application solutions from around the world. For MedTech, Neuroptek Corporation Inc from Canadian pavilion (Booth No.: 3E-D16) showcases the brand new EyeMirage, a solution that extends professional ophthalmic vision examinations beyond the clinic. By leveraging the computing power and camera technology of smartphones, the system enables users to conduct high-quality vision tests in settings such as homes and schools. Meanwhile, HKG epiTherapeutics Limited (Booth number: 3E-E06), from the Hong Kong Science and Technology Parks, presents a DNA methylation analysis technology designed for the early screening of liver cancer. The solution can identify and distinguish differential methylation features among liver cancer, blood and normal tissues. Its clinical research findings have been published in leading international academic journals[1], demonstrating a sensitivity of 88.5% for early-stage liver cancer and 95.7% for late-stage cases, representing one of the highest performance levels globally in methylation-based liver cancer early screening.In the field of GeronTech, the exhibits span a wide range of products, including smart rehabilitation robots, AI-powered mental health assessment systems, smart elderly care solutions and home-based care devices, fully addressing the evolving market needs of the silver economy. Hanshin Technology Limited (Booth No.: 3E-D13) introduces a Smart Shower Robot, which enhances safety and comfort for the elderly during bathing through intelligent design, while also easing caregivers’ workload and supporting the practical adoption of smart care solutions. Notably, the number of smart ageing products exhibited this year has more than doubled compared with the last edition, underscoring strong and growing market demand.In Preventive Healthcare, an exhibitor from Chinese Mainland, Guangzhou Supbio Bio-Technology and Science Co., Ltd. (Booth No: 3E-E19), presents the world’s first HIV-1 DNA quantitative testing kit approved for market launch by the National Medical Products Administration (NMPA). Designed to address increasingly complex HIV testing needs, the solution provides a stable and reliable full-disease-course testing approach, supporting an integrated and innovative model that spans prevention, treatment efficacy assessment and the exploration of functional cure through precision diagnostics.The Medical Fair features more than 50 themed forums and seminars, including topics such as “HKMTA Medical Fair Forum 2026: The Medtech Solutions - Greater Bay Area & Overseas”, co-organised with the Hong Kong MedTech Association, to be held tomorrow morning (12 May), followed by the afternoon session “ASEAN Gateway: Navigating Regulations, Capital and Distributions from Hong Kong”. On Wednesday (13 May), sessions such as “Decoding the Demand for Gerontechnology” will also take place. Industry experts will share the latest insights and market trends, and the exhibition will provide an ideal platform for professionals to network and explore new business opportunities. The exhibition will continue to adopt the “EXHIBITION+” hybrid model. The physical fair will take place from 11 to 13 May at the HKCEC. Global exhibitors, industry professionals, and buyers can engage in discussions via the “Click2Match” smart business matching platform from 4 May until 20 May.Photo download: https://bit.ly/4tsy9JsThe sixth Asia Summit on Global Health, jointly organised by the HKSAR government and the Hong Kong Trade Development Council, is held from 11 to 12 May at the Hong Kong Convention and Exhibition Centre under the theme “Fuelling Healthcare Breakthroughs.”Prof Frederick Ma, HKTDC Chairman, delivered the welcome remarks.John Lee, Chief Executive of the HKSAR, delivered the opening remarks.Prof Michael Levitt, 2013 Nobel Laureate in Chemistry, and the Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University, shared his insight.ASGH Deal-making has facilitated one-on-one meetings, both online and offline, to channel capital to healthcare projects and promote collaboration.The ASGH Business Hub and InnoHealth Showcase have featured around 180 healthtech companies from 12 countries and regions.Under the theme Innovations Boosting Smart Health Experience, the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair) highlights MedTech, GeronTech & Preventive Healthcare, with some 300 exhibitors from 10 countries and regions.On the first day of the Medical Fair, a series of forums and seminars were held, including “Digital Pulse, Preventive Future: When Wearable Technology Meets Chinese and Western Medicine Collaboration and AI” .The session featured Mr. Paul Anthony Yuen, Director of Dayton Industrial Co., Ltd., who joined academic experts in sharing insights into the latest developments in the field.Led by the Hong Kong Science and Technology Parks Corporation (HKSTP), DRESIO Limited showcases its AI-powered physiotherapy motion analysis system.Exhibitor from Canada bring medical technologies, highlighting clinical applications and solutions.Medical Fair exhibitor Green Life Technology Ltd (Booth No.: 3D-D24) showcases the world’s first product integrating inversion technology and 3D resonance technology, which has been successfully adopted by massage practitioners and therapists in Germany.WebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enThe Asia Summit on Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en?ref_source=GrayMenu&ref_medium=vep-conferenceHong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/en?ref_source=GrayMenu&ref_medium=vep-tradeshowList of Product: https://www.hktdc.com/event/hkmedicalfair/en/product?ref_source=GrayMenu&ref_medium=vep-tradeshowMedia enquiriesYuan Tung Financial Relations:Jasmine Zhang      Tel: (852) 3428 3278   Email: jzhang@yuantung.com.hkLouise Song        Tel: (852) 3428 5691   Email: lsong@yuantung.com.hkTiffany Leung      Tel: (852) 3428 2361   Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Noah Qiu           Tel (852) 2584 4575    Email: noah.yl.qiu@hktdc.orgNavin Law          Tel: (852) 2584 4525   Email: navin.cm.law@hktdc.orgJane Cheung        Tel: (852) 2584 4137   Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. [1] The product was published in the world-leading academic journal Nature Communications (2023). Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, May 11, 2026 - (ACN Newswire via SeaPRwire.com) - Managing daily expenses can feel overwhelming, especially when bills, subscriptions, and lifestyle spending happen across different platforms. However, organising payments strategically using credit cards and cashbacks, and structured spending habits can help unlock better control, higher cashback, and long-term savings. In Singapore, where digital payments are widely accepted, aligning expenses smartly can help turn routine spending into value-earning opportunities.Unplanned spending often results in missed reward opportunities and unnecessary fees. When payments are scattered across multiple methods, tracking expenses becomes difficult, and potential cashback categories may go underutilised.In 2023, the average monthly household expenditure in Singapore was SGD 5,931. When monthly recurring payments are aligned under suitable cards, even a modest cashback rate of 1.5-5% can add up meaningfully over time.If you are looking to make the best use of your cashback credit cards and maximise your savings, here are some tips that you might find useful.Understand your monthly spending categoriesBefore selecting or using credit cards strategically, it helps to map out where money is being spent each month. This exercise can help distinguish between fixed recurring expenses and flexible lifestyle spending. With digital payments now a common part of daily life, small expenses can add up quickly without you noticing.Typical monthly spending categories may include groceries, transport, dining, utilities, mobile bills, insurance premiums, and online shopping. On average, Singaporeans spend around SGD 455 per month on food and groceries alone and an additional SGD 128 per month on public transport.When these categories are clearly defined, it is easier to identify which expenses qualify for cashback and which do not.Match the right Credit Card to the right expenseDifferent credit cards are designed to reward different types of spending. Some cards focus heavily on dining and entertainment, while others provide higher cashback on groceries, transport, or online purchases.For example, one card may offer 5% cashback on dining capped at SGD 50 monthly, while another provides 3-4% on online shopping and subscriptions. When all expenses are charged randomly to a single card, these benefits may remain underutilised.Assigning specific cards to specific expense categories can help structure spending without increasing it. This method allows users to stay within cashback limits, reduce confusion, and improve the efficiency of rewards across everyday transactions.Automate recurring bills for consistent cashbackAutomating recurring payments can help maintain consistency in both budgeting and cashback accumulation. Many essential services support automatic card payments, including utilities, broadband, mobile plans, and digital subscriptions.Automation also reduces the risk of missed due dates and late payment fees.Use cashback earned in practical waysCashback earned through credit card usage can be more useful when applied intentionally rather than treated as incidental savings. Instead of viewing it as extra money, cashback can help offset regular expenses and improve monthly cash flow. When planned properly, even small amounts earned each month can support everyday budgeting.Some practical ways cashback may be used include:Offsetting utility or telco billsHousehold expenses such as electricity, water, mobile, and broadband form a significant portion of regular monthly spending. Cashback credited to the card statement can reduce these fixed expenses directly, helping stabilise monthly outflow.Reducing grocery spendingUsing cashback to offset statement balances can help cover weekly grocery and essentials from supermarkets, easing the impact of rising grocery costs.Covering transport expensesMRT travel, ride-hailing services, and fuel expenses can be a big expense if not planned well. Cashback can be redirected towards SimplyGo top-ups or occasional Grab rides, helping manage daily commute costs.Supporting annual or seasonal expensesAccumulated cashback from payments may help offset insurance premiums, travel bookings, or festive shopping, reducing the pressure of large one-time payments. Used consistently, cashback can quietly strengthen everyday financial planning without changing spending habits.Align large purchases with reward periodsLarger purchases, such as electronics, furniture, or travel bookings, can sometimes be planned around bank promotional periods. In Singapore, many credit card providers run limited-time campaigns during events like the Great Singapore Sale, year-end holidays, or major online shopping festivals. During these periods, users may receive additional cashback, higher reward caps, or bonus returns on select categories, subject to promotional terms and conditions.Aligning such spending with promotional windows can help convert unavoidable costs into reward-generating transactions. Over time, this approach can support better savings outcomes while keeping overall spending controlled.Final thoughtsOrganising payments thoughtfully can help transform daily expenses into meaningful rewards. By aligning spending categories, automating bill payments, tracking spending limits, and using cashback strategically, Singapore consumers may find greater value in routine transactions.While results vary based on lifestyle and spending patterns, a structured approach can help create clarity, flexibility, and small yet steady savings over time. With the right planning, cashback and credit cards can become practical tools that support smarter money management rather than complicate it.Disclaimer: This content is published by iQuanti Singapore Pte. Ltd., an external marketer engaged and compensated by UOB Ltd.Contact Information:Name: Sonakshi MurzeEmail: Sonakshi.murze@iquanti.comJob Title: ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BRISBANE, AUS, May 11, 2026 - (ACN Newswire via SeaPRwire.com) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce GMG's energy saving and anti-corrosion graphene coating solution, THERMAL-XR, is being applied to the air conditioners for two luxury towers in Australia currently under construction at the Gold Coast in Queensland (the "Project"). The Project includes spraying THERMAL-XR on a total of between 300 to 600 air conditioners, see Figure 1 showing how the THERMAL-XR is sprayed on the air conditioners in GMG's spray booth facility in Brisbane Queensland.Figure 1: Spray Booth and Curing Area for Air Conditioners for ProjectTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/296885_3b33c46414878a4d_001full.jpgCraig Nicol, CEO & Managing Director of the Company, commented "Great to see two of the largest towers in Australia using THERMAL-XR on their air conditioners to save energy for the apartment owners and tenants as well as limiting corrosion and extending the air conditioners' life."Jack Perkowski, Non-Executive Chairman and Director of the Company, commented: "This project is a great demonstration of the commercial momentum THERMAL-XR is building in the Australian market. Seeing our graphene coating applied to up to 600 air conditioners across two of Australia's most prestigious luxury towers is a significant milestone - not only for the energy savings and extended asset life it is expected to deliver to apartment owners and tenants, but as a compelling proof point for the broader HVAC-R industry. Projects of this scale highlight the real-world value that GMG's technology brings and reinforce our path to building a substantial revenue base from our energy savings products."Figure 2To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/296885_gmgfigure2.jpgAbout THERMAL-XR® ENHANCE powered by GMG Graphene: THERMAL-XR® ENHANCE coating system is a unique patent product and method of improving the conductivity of heat exchange surfaces (including for air conditioners, refrigeration systems, heat pumps and data centres) and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces from corrosion (successfully passed up to 20,000 hours of salt sea spray corrosion testing) while improving the corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed at improving the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "believes" "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, THERMAL-XR coating on the Project's air conditioners, the energy savings, anti-corrosion and extension of asset life attributes of THERMAL-XR, the momentum THERMAL-XR is experiencing in Australia, the ability of GMG's energy savings products to build a revenue base, GMG's intentions to develop commercial scale-up capabilities, GMG's focus in the energy savings segment, GMG's intentions for the use of graphene lubricant additive on saving liquid fuels, expectations for R&D and commercialization of G+AI Batteries, GMG's ability to improve the performance of lithium-ion batteries and GMG's critical business objectives.Such forward-looking statements are based on a number of assumptions of management, including the coating of air conditioners on Meriton's two towers. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation that GMG does not receive or receive on a timely basis the fully signed consent notice from the and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296885 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月11日 - (亚太商讯 via SeaPRwire.com) - 联合评级国际有限公司（"联合国际"）近日发布跟踪评级结果，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"，股份代号：1788.HK）旗下全资资管平台——国泰君安资产管理（亚洲）有限公司所管理的两只基金：国泰君安港元货币市场基金与国泰君安美元货币市场基金，双双维持"AAAmf"货币市场基金("MMF")评级，充分展现了国泰君安国际在境外现金管理领域具备行业领先的专业能力与卓越的风险控制水平。本次获评"AAAmf"评级的两只基金均于2023年4月在香港注册成立，分别以港元及美元计价，专注为机构、企业及个人投资者提供高安全性、高流动性、稳健回报的现金管理工具，投资目标为追求与相关货币市场利率相一致的稳定回报。联合国际依据《货币市场基金评级准则》（2024年2月1日发布），从资产质量、信用水平、流动性管理、期限结构、风险控制等多个核心维度开展全面跟踪评审，最终确认两只基金均持续满足"AAAmf"评级标准，代表基金具备极强的流动性保障与本金安全能力，亦是国际评级体系对货币市场基金的最高评价。评级结果显示，两只基金在多方面表现突出，完全契合最高评级要求：一是资产质量优良，信用风险严控。基金主要投资对应币种短期存款及优质货币工具，资产加权平均信用质量达 BBB + 以上高投资级，集中度风险管控到位，并持续监控目标信用状况；二是流动性管理稳健，申赎保障充足。基金流动性充裕，可有效应对申赎需求。同时，组合久期严控，加权平均到期日低于 60 天、加权平均期限低于 120 天，市场风险处于较低水平；三是风控体系严谨，汇率风险有效对冲。基金衍生品仅用于对冲，非本币资产均对冲为基金计价货币，货币风险管理严谨，运作稳健可控。此次两只货币基金同获"AAAmf"评级，是国际权威评级机构对国泰君安国际及旗下资管平台投资管理能力、风险控制体系、产品运作规范性的高度认可，进一步彰显了公司在离岸现金管理领域的领先地位。近年来，全球市场波动加剧，低风险、高流动性的现金管理工具需求持续攀升，两只高评级货币基金凭借安全性高、流动性强、运作透明的优势，已成为离岸市场港元、美元现金管理的标杆选择，为投资者跨境资产配置提供坚实的"安全垫"。国泰君安资产管理（亚洲）有限公司作为国泰君安国际全资子公司，依托国泰海通集团的强大股东背景与综合金融实力，深耕香港及离岸资产管理市场，为全球客户提供覆盖固定收益、货币市场、多元资产等领域的专业资产管理服务。公司坚持稳健合规、专业精进的理念，搭建覆盖投研、风控、运营的全流程管理体系，凭借对离岸市场的专业研判与丰富运作经验，打造出一系列适配机构资金、企业闲置资金、高净值客户现金管理需求的优质产品。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK），是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高质量、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的信息请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月11日 - (亚太商讯 via SeaPRwire.com) - 今日，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"，股份代号：1788.HK）作为联席保荐人、保荐人兼整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人，携手集团旗下海通国际共同助力深圳乐动机器人股份有限公司（简称"乐动机器人"，股票代码：1236.HK）在香港交易所主板成功上市，展现出国泰海通以金融赋能高新技术企业国际化发展的卓越能力。 此次发行最终定价为每股26.36港元，总发售股数达33,333,400股，总集资额约为8.8亿港元，充分反映了市场对乐动机器人在视觉感知技术解决方案领域领先地位及未来增长潜力的高度认可。在项目推进过程中，国泰海通充分发挥跨境一体化投行服务体系优势，依托旗下子公司在跨境资本市场的专业能力以及对行业的深入理解，为乐动机器人提供全方位资本市场支持。国泰君安国际作为项目的核心参与方，凭借对智能机器人赛道的前瞻性布局与贯穿全程的专业服务，为乐动机器人的跨境资本运作注入了关键助力。本项目的高效执行与顺利完成，亦体现了国泰君安国际以一站式跨境金融服务助力中国高新技术企业扬帆国际资本市场的积极作为与专业实力。未来，国泰君安国际将在集团的带领下，继续秉持金融服务实体经济的初心，积极发挥综合金融服务能力与境内外资源整合优势，以专业投行能力赋能更多高新技术企业扬帆国际资本市场。关于乐动机器人乐动机器人成立于2017年，是一家提供视觉感知产品及割草机器人的公司，业务覆盖多款智能机器人激光雷达创新产品。根据招股文件，视觉感知产品是企业第一增长曲线，2025年搭载企业视觉感知技术的智能机器人超过900万台。同年，DTOF激光雷达出货量超过400万台，位居行业首位。而智能割草机器人的场景适应性与环境感知水平不断提升，已成为第二增长曲线，第一代产品于2024年量产并实现销售突破10,000台，第二代产品于次年量产。乐动机器人总部位于中国，正战略性扩大在海外市场的业务布局，积极在新加坡、德国等地设立运营中心，在越南建立生产合作关系，以实现海外研发、生产、销售及服务的高效协同。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK）,是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高品质、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的资讯请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com